Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2017

Open Access 01-12-2017 | Research article

Acacia hydaspica R. Parker prevents doxorubicin-induced cardiac injury by attenuation of oxidative stress and structural Cardiomyocyte alterations in rats

Authors: Tayyaba Afsar, Suhail Razak, Khalid Mujasam Batoo, Muhammad Rashid Khan

Published in: BMC Complementary Medicine and Therapies | Issue 1/2017

Login to get access

Abstract

Background

The use of doxorubicin (DOX) an anthracycline antineoplastic agent is withdrawn due to its cardio-toxic side effects. Oxidative stress has been recognized as the primary cause of DOX induced cardiotoxicity. We have investigated whether polyphenol rich ethyl acetate extract of Acacia hydaspica (AHE) can attenuate doxorubicin-induced cardiotoxicity via inhibition of oxidative stress.

Methods

AHE was administered orally to rats once daily for 6 weeks at doses of 200 and 400 mg/kg b.w. DOX (3 mg/kg b.w. i.p., single dose/week) was administered for 6 weeks (chronic model). The parameters studied to evaluate cardioprotective potential were the serum cardiac function biomarkers (CK, CKMB, AST and LDH), hematological parameters, cardiac tissue antioxidant enzymatic status and oxidative stress markers, and histopathological analysis to validate biochemical findings.

Results

Chronic 6 week treatment of DOX significantly deteriorated cardiac function biomarkers and decreased the activities of antioxidant enzymes, whereas significant increase in oxidative stress biomarkers was noticed in comparison to control group. AHE dose dependently protected DOX-induced leakage of cardiac enzymes in serum and ameliorated DOX-induced oxidative stress; as evidenced by decreasing lipid peroxidation, H2O2 and NO content with increase in phase I and phase II antioxidant enzymes. Doxorubicin treatment produced severe morphological lesions, leucopenia, decrease in red blood cell counts and hemoglobin concentrations. AHE co-treatment protected the heart and blood elements from the toxic effects of doxorubicin as indicated by the recovery of hematological parameters to normal values and prevention of myocardial injuries in a dose dependent way. The protective potency of AHE (400 mg/kg b.w) was equivalent to silymarin.

Conclusion

Results revealed that AHE showed protective effects against DOX induce cardiotoxicity. The protective effect might attribute to its polyphenolic constituents and antioxidant properties. AHE might be helpful in combination therapies as safer and efficient.
Literature
1.
Aleman BM, Moser EC, Nuver J, Suter TM, Maraldo MV, Specht L, Vrieling C, Darby SC. Cardiovascular disease after cancer therapy. Eur J Cancer Suppl. 2014;12(1):18–28.CrossRef
2.
Blum RH, Carter SK. Adriamycin: a new anticancer drug with significant clinical activity. Ann Intern Med. 1974;80(2):249–59.CrossRefPubMed
3.
Chang Y-L, Lee H-J, Liu S-T, Lin Y-S, Chen T-C, Hsieh T-Y, Huang H-S, Huang S-M. Different roles of p53 in the regulation of DNA damage caused by 1, 2-heteroannelated anthraquinones and doxorubicin. Int J Biochem Cell Biol. 2011;43(12):1720–8.CrossRefPubMed
4.
Sahna E, Parlakpinar H, Ozer MK, Ozturk F, Ozugurlu F, Acet A. Melatonin protects against myocardial doxorubicin toxicity in rats: role of physiological concentrations. J Pineal Res. 2003;35(4):257–61.CrossRefPubMed
5.
Mohan M, Kamble S, Gadhi P, Kasture S. Protective effect of Solanum Torvum on doxorubicin-induced nephrotoxicity in rats. Food Chem Toxicol. 2010;48(1):436–40.CrossRefPubMed
6.
Thippeswamy A, Shirodkar A, Koti B, Sadiq AJ, Praveen D, Swamy AV, Patil M. Protective role of Phyllantus niruri extract in doxorubicin-induced myocardial toxicity in rats. Indian J Pharmacol. 2011;43(1):31.CrossRefPubMedPubMedCentral
7.
Injac R, Perse M, Cerne M, Potocnik N, Radic N, Govedarica B, Djordjevic A, Cerar A, Strukelj B. Protective effects of fullerenol C 60 (OH) 24 against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer. Biomaterials. 2009;30(6):1184–96.CrossRefPubMed
8.
Yilmaz S, Atessahin A, Sahna E, Karahan I, Ozer S. Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity. Toxicology. 2006;218(2):164–71.CrossRefPubMed
9.
Steinherz LJ, Steinherz PG, Tan CT, Heller G, Murphy ML. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA. 1991;266(12):1672–7.CrossRefPubMed
10.
Dudka J, Burdan F, Korga A, Dyndor K, Syroka I, Zieba J, Lewkowicz D, Korobowicz-Markiewicz A. The diagnosis of anthracycline-induced cardiac damage and heart failure. Postepy Hig Med Dosw (Online). 2008;63:225–33.
11.
Feola M, Garrone O, Occelli M, Francini A, Biggi A, Visconti G, Albrile F, Bobbio M, Merlano M. Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide. Int J Cardiol. 2011;148(2):194–8.CrossRefPubMed
12.
Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev. 2004;56(2):185–229.CrossRefPubMed
13.
Korga A, Dudka J, Burdan F, Sliwinska J, Mandziuk S, Dawidek-Pietryka K. The redox imbalance and the reduction of contractile protein content in rat hearts administered with L-thyroxine and doxorubicin. Oxidative Med Cell Longev. 2012;2012:681367.CrossRef
14.
Xu MF, Tang PL, Qian ZM, Ashraf M. Effects by doxorubicin on the myocardium are mediated by oxygen free radicals. Life Sci. 2001;68(8):889–901.CrossRefPubMed
15.
Torres VM, Simic VD. Doxorubicin-induced oxidative injury of cardiomyocytes-do we have right strategies for prevention? InCardiotoxicity of oncologic treatments 2012. InTech. ISBN 978-953-51-0273-1. 2012.
16.
Tapas AR, Sakarkar D, Kakde R. Flavonoids as nutraceuticals: a review. Trop J Pharm Res. 2008;7(3):1089–99.CrossRef
17.
Soobrattee MA, Neergheen VS, Luximon-Ramma A, Aruoma OI, Bahorun T. Phenolics as potential antioxidant therapeutic agents: mechanism and actions. Mutat Res. 2005;579(1):200–13.CrossRefPubMed
18.
Aydin B, Unsal M, Sekeroglu ZA, Gülbahar Y. The antioxidant and antigenotoxic effects of Pycnogenol® on rats treated with cisplatin. Biol Trace Elem Res. 2011;142(3):638–50.CrossRefPubMed
19.
Lee CK, Son SH, Park KK, Park JHY, Lim SS, Kim SH, Chung WY. Licochalcone a inhibits the growth of colon carcinoma and attenuates Cisplatin-induced toxicity without a loss of chemotherapeutic efficacy in mice. Basic Clin Pharmacol Toxicol. 2008;103(1):48–54.CrossRefPubMed
20.
Seigler DS. Phytochemistry of Acacia—Sensu Lato. Biochem Syst Ecol. 2003;31(8):845–73.CrossRef
21.
Sakthivel K, Kannan N, Angeline A, Guruvayoorappan C. Anticancer activity of Acacia Nilotica (L.) wild. Ex. Delile Subsp. Indica against Dalton’s ascitic lymphoma induced solid and ascitic tumor model. Asian Pac J Cancer Prev. 2012;13(8):3989–95.CrossRefPubMed
22.
Duarte MR, Wolf S. Anatomical characters of the phyllode and stem of Acacia Podalyriifolia a. Cunn. Ex G. Don (Fabaceae). Rev Bras. 2005;15(1):71–6.
23.
Chakrabarty T, Gangopadhyay M. The genus acacia P. Miller (Leguminosae: Mimosoideae) in India. J Econ Taxon Bot. 1996;20(3):599–633.
24.
Afsar T, Khan MR, Razak S, Ullah S, Mirza B. Antipyretic, anti-inflammatory and analgesic activity of Acacia Hydaspica R. Parker and its phytochemical analysis. BMC Complement Altern Med. 2015;15(1):136.CrossRefPubMedPubMedCentral
25.
Afsar T, Razak S, Khan MR, Almajwal A. Anti-depressant and anxiolytic potential of Acacia Hydaspica R. Parker aerial parts extract: modulation of brain antioxidant enzyme status. BMC Complement Altern Med. 2017;17(1):228.CrossRefPubMedPubMedCentral
26.
Afsar T, Razak S, Khan MR, Mawash S, Almajwal A, Shabir M, Haq IU. Evaluation of antioxidant, anti-hemolytic and anticancer activity of various solvent extracts of Acacia Hydaspica R. Parker aerial parts. BMC Complement Altern Med. 2016;16:258.CrossRefPubMedPubMedCentral
27.
Afsar T, Trembley JH, Salomon CE, Razak S, Khan MR, Ahmed K. Growth inhibition and apoptosis in cancer cells induced by polyphenolic compounds of Acacia Hydaspica: involvement of multiple signal transduction pathways. Sci Rep. 2016;6:23077.CrossRefPubMedPubMedCentral
28.
Ojha S, Al Taee H, Goyal S, Mahajan UB, Patil CR, Arya D, Rajesh M. Cardioprotective potentials of plant-derived small molecules against doxorubicin associated Cardiotoxicity. Oxidative Med Cell Longev. 2016;2016:5724973.
29.
Elderbi MA, Mohamed A-WH, Hadi A-HA, Dabobash MD. Potential protective effect of gum Arabic against doxorubicin-induced Cardiotoxicity in Wistar albino rats. Int J Pharm Sci Res. 2014;5(3):1023.
30.
Zhao X, Zhang J, Tong N, Chen Y, Luo Y. Protective effects of berberine on doxorubicin-induced hepatotoxicity in mice. Biol Pharm Bull. 2012;35(5):796–800.CrossRefPubMed
31.
Oda SS, El-Ashmawy IM. Protective effect of silymarin on mercury-induced acute nephro-hepatotoxicity in rats. Glob Vet. 2012;9(4):376–83.
32.
Guideline OO. 425: acute oral toxicity—up-and-down procedure. OECD Guidelines for the Testing of Chemicals. 2001;2:12–6.
33.
Irwin S. Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacology. 1968;13(3):222–57.CrossRef
34.
Mensah A, Mireku E, Mensah M, Amponsah I. Some neurological effects of the ethanolic stem bark extract of Cussonia bancoensis Aubrev and Pellgr (Araliaceae). J Pharmacognosy Phytochemistry. 2014;2(6):101–6.
35.
van Acker FA, van Acker SA, Kramer K, Haenen GR, Bast A, van der Vijgh WJ. 7-monohydroxyethylrutoside protects against chronic doxorubicin-induced cardiotoxicity when administered only once per week. Clin Cancer Res. 2000;6(4):1337–41.PubMed
36.
Jalali AS, Hasanzadeh S. Crataegus Monogyna fruit aqueous extract as a protective agent against doxorubicin-induced reproductive toxicity in male rats. Avicenna J Phytomed. 2013;3(2):159.
37.
Sakr SA, Mahran HA, Lamfon HA. Protective effect of ginger (Zingiber Officinale) on adriamycin-induced hepatotoxicity in albino rats. J Med Plant Res. 2011;5(1):133–40.
38.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265–75.PubMed
39.
Chance B, Maehly A. Assay of catalases and peroxidases. Methods Biochem Anal. 1954;1:357–424.PubMed
40.
Kakkar P, Das B, Viswanathan P. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys. 1984;21(2):130–2.PubMed
41.
Benson AM, Hunkeler MJ, Talalay P. Increase of NAD (P) H: quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. Proc Natl Acad Sci. 1980;77(9):5216–20.CrossRefPubMedPubMedCentral
42.
Jollow D, Mitchell J, Zampaglione N, Gillette J. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3, 4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology. 1974;11(3):151–69.CrossRefPubMed
43.
Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases the first enzymatic step in mercapturic acid formation. J Biol Chem. 1974;249(22):7130–9.PubMed
44.
Carlberg I, Mannervik B. Purification and characterization of the flavoenzyme glutathione reductase from rat liver. J Biol Chem. 1975;250(14):5475–80.PubMed
45.
Mohandas J, Marshall JJ, Duggin GG, Horvath JS, Tiller DJ. Differential distribution of glutathione and glutathione-related enzymes in rabbit kidney: possible implications in analgesic nephropathy. Biochem Pharmacol. 1984;33(11):1801–7.CrossRefPubMed
46.
Orlowski M, Sessa G, Green JP. γ-Glutamyl transpeptidase in brain capillaries: possible site of a blood-brain barrier for amino acids. Science. 1974;184(4132):66–8.CrossRefPubMed
47.
Iqbal S, Bhanger M, Anwar F. Antioxidant properties and components of some commercially available varieties of rice bran in Pakistan. Food Chem. 2005;93(2):265–72.CrossRef
48.
Pick E, Mizel D. Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J Immunol Methods. 1981;46(2):211–26.CrossRefPubMed
49.
Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15 N] nitrate in biological fluids. Anal Biochem. 1982;126(1):131–8.CrossRefPubMed
50.
Fadillioglu E, Oztas E, Erdogan H, Yagmurca M, Sogut S, Ucar M, Irmak MK. Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats. J Appl Toxicol. 2004;24(1):47–52.CrossRefPubMed
51.
El-Awady E-SE, Moustafa YM, Abo-Elmatty DM, Radwan A. Cisplatin-induced cardiotoxicity: mechanisms and cardioprotective strategies. Eur J Pharmacol. 2011;650(1):335–41.CrossRef
52.
Dudka J, Gieroba R, Korga A, Burdan F, Matysiak W, Jodlowska-Jedrych B, Mandziuk S, Korobowicz E, Murias M. Different effects of resveratrol on dose-related doxorubicin-induced heart and liver toxicity. Evid Based Complement Alternat Med. 2012;2012:606183.CrossRefPubMedPubMedCentral
53.
Chrostek L, Szmitkowski M. Enzymatic diagnosis of alcoholism-induced damage of internal organs. Psychiatr Pol. 1988;23(5–6):353–60.
54.
Khan MR, Haroon J, Khan RA, Bokhari J, Rashid U. Prevention of KBrO3-induced cardiotoxicity by Sonchus Asper in rat. J Med Plants Res. 2011;5(12):2514–20.
55.
Adams JE, Sicard GA, Allen BT, Bridwell KH, Lenke LG, Davila-Roman VG, Bodor GS, Ladenson JH, Jaffe AS. Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. N Engl J Med. 1994;330(10):670–4.CrossRefPubMed
56.
Kurian GA, Philip S, Varghese T. Effect of aqueous extract of the Desmodium Gangeticum DC root in the severity of myocardial infarction. J Ethnopharmacol. 2005;97(3):457–61.CrossRefPubMed
57.
Rajadurai M, Prince PSM. Preventive effect of naringin on cardiac markers, electrocardiographic patterns and lysosomal hydrolases in normal and isoproterenol-induced myocardial infarction in Wistar rats. Toxicology. 2007;230(2):178–88.CrossRefPubMed
58.
El-Sayed EM, El-azeem ASA, Afify AA, Shabana MH, Ahmed HH. Cardioprotective effects of Curcuma Longa L. extracts against doxorubicin-induced cardiotoxicity in rats. J Med Plants Res. 2011;5(17):4049–58.
59.
Potluri S, Ventura HO, Mulumudi M, Mehra MR. Cardiac troponin levels in heart failure. Cardiol Rev. 2004;12(1):21–5.CrossRefPubMed
60.
Kulkarni J, Swamy AV. Cardioprotective effect of gallic acid against doxorubicin-induced myocardial toxicity in albino rats. Indian J Health Sci Biomed Res (KLEU). 2015;8(1):28.CrossRef
61.
Joshi P, Bose M, Harish D. Haematological changes in the blood of Clarias Batrachus exposed to mercuric chloride. J Ecotoxicol Environ Monit. 2002;12(2):119–22.
62.
Al-Harbi M, Al-Gharably NM, Al-Shabanah OA, Al-Bekairi AM, Osman AMM, Tawfik HN. Prevention of doxorubicin-induced myocardial and haematological toxicities in rats by the iron chelator desferrioxamine. Cancer Chemother Pharmacol. 1992;31(3):200–4.CrossRefPubMed
63.
Kim EJ, Lim KM, Kim KY, Bae ON, Noh JY, Chung SM, Shin S, Yun YP, Chung JH. Doxorubicin-induced platelet cytotoxicity: a new contributory factor for doxorubicin-mediated thrombocytopenia. J Thromb Haemost. 2009;7(7):1172–83.CrossRefPubMed
64.
Adewale AL. Evaluation of Root Extract of Acacia nilotica on Haematological and Lipid Profile in Rats. Eur J Med Plants. 2016;17(4):1-7.
65.
Sakthivel K, Guruvayoorappan C. Acacia Ferruginea inhibits cyclophosphamide-induced immunosuppression and urotoxicity by modulating cytokines in mice. J Immunotoxicol. 2015;12(2):154–63.CrossRefPubMed
66.
Kyle ME, Nakae D, Sakaida I, Serroni A, Farber JL. Protein thiol depletion and the killing of cultured hepatocytes by hydrogen peroxide. Biochem Pharmacol. 1989;38(21):3797–805.CrossRefPubMed
67.
Nicolson GL, Conklin KA. Reversing mitochondrial dysfunction, fatigue and the adverse effects of chemotherapy of metastatic disease by molecular replacement therapy. Clin Exp Metastasis. 2008;25(2):161–9.CrossRefPubMed
68.
Satoh M, Kashihara N, Fujimoto S, Horike H, Tokura T, Namikoshi T, Sasaki T, Makino H. A novel free radical scavenger, edarabone, protects against cisplatin-induced acute renal damage in vitro and in vivo. J Pharmacol Exp Ther. 2003;305(3):1183–90.CrossRefPubMed
69.
Karthikeyan K, Bai BS, Devaraj SN. Cardioprotective effect of grape seed proanthocyanidins on isoproterenol-induced myocardial injury in rats. Int J Cardiol. 2007;115(3):326–33.CrossRefPubMed
70.
Zarei M, Javarappa KK, Zarei M, Baker S. Cardioprotective effect of the root extract of Hemidesmus indicus against doxorubicin-induced oxidative stress in mice. Pharm Lett. 2013;5(1):334–9.
71.
Rao PR, Viswanath RK. Cardioprotective activity of silymarin in ischemia-reperfusion-induced myocardial infarction in albino rats. Exp Clin Cardiol. 2007;12(4):179.PubMedPubMedCentral
72.
Kozluca O, Olcay E, Sürücü S, Güran Z, Kulaksiz T, Üskent N. Prevention of doxorubicin induced cardiotoxicity by catechin. Cancer Lett. 1996;99(1):1–6.CrossRefPubMed
73.
El-Aziz TAA, Mohamed RH, Pasha HF, Abdel-Aziz HR. Catechin protects against oxidative stress and inflammatory-mediated cardiotoxicity in adriamycin-treated rats. Clin Exp Med. 2012;12(4):233–40.CrossRef
74.
Nimse SB, Pal D. Free radicals, natural antioxidants, and their reaction mechanisms. RSC Adv. 2015;5(35):27986–8006.CrossRef
75.
Du Y, Guo H, Lou H. Grape seed polyphenols protect cardiac cells from apoptosis via induction of endogenous antioxidant enzymes. J Agric Food Chem. 2007;55(5):1695–701.CrossRefPubMed
76.
El-Shitany NA, El-Haggar S, El-Desoky K. Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats. Food Chem Toxicol. 2008;46(7):2422–8.CrossRefPubMed
77.
Morishima I, Matsui H, Mukawa H, Hayashi K, Toki Y, Okumura K, Ito T, Hayakawa T. Melatonin, a pineal hormone with antioxidant property, protects against adriamycin cardiomyopathy in rats. Life Sci. 1998;63(7):511–21.CrossRefPubMed
78.
Rašković A, Stilinović N, Kolarović J, Vasović V, Vukmirović S, Mikov M. The protective effects of silymarin against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats. Molecules. 2011;16(10):8601–13.PubMed
79.
Du Y, Lou H. Catechin and proanthocyanidin B4 from grape seeds prevent doxorubicin-induced toxicity in cardiomyocytes. Eur J Pharmacol. 2008;591(1):96–101.CrossRefPubMed
80.
Singh G, Singh AT, Abraham A, Bhat B, Mukherjee A, Verma R, Agarwal SK, Jha S, Mukherjee R, Burman AC. Protective effects of Terminalia Arjuna against doxorubicin-induced cardiotoxicity. J Ethnopharmacol. 2008;117(1):123–9.CrossRefPubMed
Metadata
Title
Acacia hydaspica R. Parker prevents doxorubicin-induced cardiac injury by attenuation of oxidative stress and structural Cardiomyocyte alterations in rats
Authors
Tayyaba Afsar
Suhail Razak
Khalid Mujasam Batoo
Muhammad Rashid Khan
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2017
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-017-2061-0

Other articles of this Issue 1/2017

BMC Complementary Medicine and Therapies 1/2017 Go to the issue

Research article

Effects of Bu Shen Yi sui capsule on NogoA/NgR and its signaling pathways RhoA/ROCK in mice with experimental autoimmune encephalomyelitis

Research article

Effects of Salvia miltiorrhiza extract with supplemental liquefied calcium on osteoporosis in calcium-deficient ovariectomized mice

Research article

The anti-cancer effects of Tualang honey in modulating breast carcinogenesis: an experimental animal study

Research article

Potential effectiveness of Chinese herbal medicine Yu ping feng san for adult allergic rhinitis: a systematic review and meta-analysis of randomized controlled trials

Research article

Solanum nigrum Unripe fruit fraction attenuates Adriamycin resistance by down-regulating multi-drug resistance protein (Mdr)-1 through Jak-STAT pathway

Research article

High prevalence of complementary and alternative medicine use among patients with sickle cell disease in a tertiary hospital in Lagos, South West, Nigeria